> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Integrate Key Teams for CNPV Success: Expert
- URL: https://www.fdaweb.com/integrate-key-teams-for-cnpv-success-expert/
- Published: 2025-12-03T12:00:00.000Z
- Updated: 2026-09-14T15:28:07.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5160319

Veristat principal regulatory specialist **John Kirk** says sponsors looking to participate in the FDA Commissioner’s National Priority Voucher (CNPV) program will do best with the program’s compressed timelines (review in one to two months) if they integrate their biostatistics, regulatory, and medical writing teams from the outset, creating a unified approach where data flows seamlessly from analysis through narrative to submission, rather than treating them as sequential handoffs. Writing in an online [post](https://www.appliedclinicaltrialsonline.com/view/how-fda-cnpv-program-reshaping-trial-operations-accelerated-review-strategies?ref=fdaweb.com) breaking down the program. Kirk notes that 15 CNPV vouchers have already been awarded to sponsors who had development projects in their pipelines that met at least one of the priorities of the CNPV pilot project (addressing a public health crisis; addressing a large, unmet medical need; increasing affordability, etc.).

He says sponsors must submit the Chemistry, Manufacturing, Controls section of the application at least 60 days before submitting the complete application, meaning that manufacturing must be commercially ready sooner than necessary for a standard NDA. Also, he writes, clinical trials needed for the marketing application (or efficacy supplement) must be completed on time and be of high quality to facilitate review and pre-approval inspections.

“We’ve found that the ability to provide comprehensive responses quickly often comes down to having established workflows where team members already understand each other’s processes and can mobilize fast,” Kirk says. “Rapid response teams by functional area are also necessary, with clear escalation paths and pre-aligned decision-making authority to avoid bottlenecks.” Sponsors also will require well-organized vendors and partners, and pre-audited study sites to ensure high-quality datasets, he adds.